glp-1 ra drugs Indications for GLP-1/GIP Summary Sheet and Beyond! Research shows GLP-1 drugs are

Alzheimers disease is type 3 diabetes-evidence reviewed

How can we protect your muscle mass, bone mass and metabolism

19-22 With the exception of linagliptin, the DPP-4 inhibitors are primarily cleared by the kidneys and, thus, require renal dose adjustment

Early studies suggest semaglutide may help with PMOS-related symptoms like insulin resistance and body size, as well as BMI and waist circumference

Ginger or peppermint tea, as well as acupressure bands, can be beneficial

Risk of Retained Gastric Contents in Patients Using GLP-1RAs or Tirzepatide Presenting for Endoscopy or General Anesthesia Retrospective studies suggest that individuals on GLP-1-based therapy (exenatide, liraglutide, dulaglutide, semaglutide, or tirzepatide) appear to be at an increased risk of having retained gastric contents [Supplementary Table S3 (21)